21.1 Pediatric Laboratory Practices: Blood Conservation, Sampling Timing & Age-Specific Reference Intervals
Key Takeaways
- Circulating blood volume is roughly 90 to 100 mL/kg in preterm neonates, 80 to 85 mL/kg at term, 75 to 80 mL/kg in infants, and 70 to 75 mL/kg in older children, so a 4 mL tube drawn from a 1 kg preterm infant removes about 4% of the entire circulating volume.
- Commonly applied limits cap diagnostic phlebotomy at roughly 3% of total blood volume in any 24-hour period and 5% to 10% over 8 weeks, and most institutional review boards limit research-only draws in children to about 3 mL/kg per 24 hours and 7 mL/kg per 8 weeks.
- Vancomycin troughs must be drawn within 30 minutes before the next dose and aminoglycoside peaks 30 minutes after the end of a 30-minute infusion; a level drawn before steady state or at the wrong point in the interval produces a mathematically valid but clinically meaningless dose change.
- Alkaline phosphatase is physiologically two to three times the adult upper limit during periods of rapid bone growth, serum creatinine rises with muscle mass rather than with renal decline, and hemoglobin reaches a physiologic nadir near 6 to 9 weeks in term infants and 4 to 8 weeks in preterm infants.
- Heel-stick capillary sampling, underfilled 3.2% sodium citrate tubes, and drawing above a running infusion are the three most common pediatric pre-analytic errors, producing pseudohyperkalemia, falsely prolonged prothrombin time, and diluted or drug-contaminated results respectively.
21.1 Pediatric Laboratory Practices: Blood Conservation, Sampling Timing & Age-Specific Reference Intervals
The BPS Pediatric Pharmacy content outline lists Laboratory Practices (e.g., blood conservation, timing) as a distinct competency, and the reason is arithmetic. A 4 mL blood tube is a rounding error in a 70 kg adult and a transfusion trigger in a 1 kg preterm infant. Pediatric pharmacists order, interpret, and — critically — deprescribe laboratory tests, and every level they request has a blood cost.
Circulating Blood Volume: The Number Behind Every Draw
| Population | Estimated blood volume |
|---|---|
| Preterm neonate | 90–100 mL/kg |
| Term neonate | 80–85 mL/kg |
| Infant 1–12 months | 75–80 mL/kg |
| Child 1–14 years | 70–75 mL/kg |
| Adolescent / adult | 65–70 mL/kg |
Worked example. A 900 g infant born at 26 weeks has a circulating volume of roughly $0.9 \times 95 = 85\ \text{mL}$. A single 1 mL blood-gas sample is 1.2% of that infant's entire blood volume. Four such samples in a day approach 5%. This is why iatrogenic anemia of prematurity, not hemolysis or blood loss from any other source, is the leading driver of red-cell transfusion in the neonatal intensive care unit during the first weeks of life.
Volume Limits in Common Use
Exact thresholds are institutional, but the conventions converge:
- Diagnostic (clinically indicated) phlebotomy: keep cumulative draws under roughly 3% of total blood volume in any 24-hour period and 5% to 10% over 8 weeks. Some centers set a stricter ceiling for hemodynamically unstable or already anemic patients.
- Research-only draws: most institutional review boards apply a limit of about 3 mL/kg in any 24-hour period and 7 mL/kg over 8 weeks in children, with anything beyond that requiring convened-board justification. Other centers frame the same ceiling as 5% of whole blood volume over 8 weeks with a hematocrit floor at the low-normal value for age.
- Because the numbers differ across institutions, cite your own institutional policy rather than a remembered figure when documenting a recommendation.
Blood Conservation Tactics a Pharmacist Can Drive
HIERARCHY OF NEONATAL BLOOD CONSERVATION
1. DON'T DRAW IT Eliminate reflexive daily labs. A stable infant on
a stable vancomycin regimen with unchanged renal
function does not need a level every 48 hours.
2. DRAW LESS Pediatric micro-collection tubes; volumetric
absorptive microsampling (VAMS) and dried blood
spots for many TDM assays; ask the lab for the
true minimum fill, not the tube's nominal volume.
3. DRAW SMARTER Bundle draws. Use point-of-care blood gas and
glucose. Use in-line, closed-loop arterial
sampling systems that return the clearing volume.
4. REPLACE LESS Delayed cord clamping and umbilical cord blood
sampling for the newborn admission panel avoid
the first iatrogenic loss entirely.
Pharmacists carry outsized influence over step 1. Model-informed precision dosing — Bayesian vancomycin dosing from one or two concentrations rather than serial peak-and-trough pairs — halves the sampling burden while improving AUC target attainment.
Sampling Timing: When the Level Is Drawn Determines Whether It Means Anything
| Drug | Correct sample | Common error |
|---|---|---|
| Vancomycin trough | Within 30 minutes before the next dose, at steady state (generally after 3–4 doses) | Drawing mid-interval, or before steady state, then escalating the dose on a falsely low value |
| Vancomycin AUC (Bayesian) | One post-dose and one pre-dose level, or a single level with a validated population model | Treating a Bayesian estimate from a mistimed level as reliable — the model can only be as good as the recorded times |
| Aminoglycoside peak | 30 minutes after the end of a 30-minute infusion (distribution complete) | Drawing at the end of the infusion, overestimating the peak, and cutting a dose the patient needed |
| Aminoglycoside trough | Immediately pre-dose | Drawing 2 hours early in extended-interval regimens, where the concentration is still falling steeply |
| Digoxin | At least 6 hours post-dose, preferably 8–12 | Drawing during distribution, producing a falsely toxic value; note that neonates also carry endogenous digoxin-like immunoreactive substances that inflate assays |
| Phenytoin (free) | Trough; correct total phenytoin for albumin using the Sheiner-Tozer relationship, or measure the free level directly in hypoalbuminemia, uremia, or neonates | Acting on a total level in a hypoalbuminemic child and underdosing a patient whose free fraction is already high |
| Tacrolimus, cyclosporine, sirolimus | Trough, immediately pre-dose, same assay each time | Mixing assay platforms between draws |
| Busulfan | Protocol-specified timed series for AUC-targeted dosing | Any deviation from the protocol schedule invalidates the AUC |
[!IMPORTANT] Document the actual draw time, not the ordered time. A level recorded as a trough but drawn 90 minutes early is the single most common cause of an incorrect pediatric dose adjustment. If the times do not reconcile, the correct action is to repeat the level, not to adjust the dose.
Age-Specific Reference Intervals
Applying an adult reference range to a child generates false alarms and, worse, false reassurance.
| Analyte | Pediatric pattern | Practical consequence |
|---|---|---|
| Alkaline phosphatase | Two to three times the adult upper limit during infancy and the pubertal growth spurt, reflecting the bone isoenzyme | Do not stop a hepatotoxic drug for an isolated elevated ALP in a growing child; fractionate or check GGT |
| Serum creatinine | Rises steadily with muscle mass, from roughly 0.2–0.4 mg/dL in a term infant after maternal creatinine clears, to adult values in adolescence | A "normal-looking" adult creatinine in a toddler signals substantial renal impairment |
| Hemoglobin | Physiologic nadir at 6–9 weeks in term infants (roughly 9–11 g/dL) and 4–8 weeks in preterm infants (often 7–9 g/dL) | Do not treat physiologic nadir as iron deficiency; iron stores are adequate until about 4–6 months in term infants |
| White blood cells | Lymphocyte predominance from about 1 week to 4 years, then neutrophil predominance returns | An "abnormal differential" in a toddler is usually normal for age |
| Platelets | Slightly higher in infancy than adulthood | Reference-range false positives |
| Potassium | Higher in neonates (up to about 6 mEq/L in the first days) | Avoid over-treating physiologic neonatal hyperkalemia |
| Bilirubin | Physiologic unconjugated rise peaking day 3–5; interpret against the hour-specific nomogram, never a fixed cutoff | Determines phototherapy and exchange-transfusion thresholds |
| Ammonia | Higher in neonates; requires free-flowing, immediately iced sample | A tourniquet-squeezed, delayed sample fabricates hyperammonemia |
Pre-Analytic Errors That Fabricate Results
- Heel-stick capillary sampling → pseudohyperkalemia. Squeezing the heel hemolyzes red cells and releases intracellular potassium. A capillary potassium of 7.2 mEq/L in a well-appearing infant with a normal ECG is a specimen problem until a free-flowing venous sample proves otherwise. The correct action is to repeat the sample, not to give calcium gluconate.
- Underfilled 3.2% sodium citrate tube → falsely prolonged PT/INR and aPTT. Coagulation tubes require a 9:1 blood-to-citrate ratio; a short draw leaves excess citrate that chelates the reagent calcium. Pediatric-volume citrate tubes exist for exactly this reason. Conversely, a hematocrit above 55% — routine in cyanotic congenital heart disease — leaves too little plasma per unit of citrate and also prolongs results unless the citrate volume is adjusted.
- Drawing above a running infusion → dilution or contamination. Sampling a peripheral line proximal to a dextrose infusion yields an implausible glucose; sampling from a heparin-locked central line without an adequate discard yields an uninterpretable aPTT, and from a vancomycin-infusing lumen yields a spuriously enormous level. Always draw from a different limb or from a dedicated lumen after an adequate clearing volume.
- EDTA tube platelet clumping → pseudothrombocytopenia. Relevant in crizanlizumab-treated patients with sickle cell disease; repeat in a citrate tube before reacting.
- Delayed transport for lactate and ammonia. Glycolysis continues in vitro; a delayed lactate rises, and a delayed ammonia rises sharply.
Practice Pearls & BCPPS Exam Traps
- Exam Trap 1: The first response to an implausible laboratory value in a well-appearing child is to question the specimen, not to treat the number. Capillary potassium, unfilled citrate tubes, and line-contaminated drug levels account for most such values.
- Exam Trap 2: A markedly elevated alkaline phosphatase in an otherwise well 13-year-old on a new medication is most likely benign transient hyperphosphatasemia or normal pubertal bone turnover, not drug-induced cholestasis. Check GGT before discontinuing effective therapy.
- Exam Trap 3: Aminoglycoside peaks are drawn 30 minutes after the infusion ends, not at the end of the infusion; the drug is still distributing.
- Board Rule: Every additional laboratory test ordered in a neonate has a defined blood cost. If the result will not change management within the next 24 hours, the correct pharmacotherapeutic recommendation is not to draw it.
A 1.1 kg infant born at 27 weeks gestational age is receiving vancomycin and gentamicin for late-onset sepsis. Over the preceding 24 hours the neonatal team has drawn a 1 mL blood gas at 06:00, a 1 mL blood gas at 14:00, a 0.5 mL vancomycin trough, and a 1.5 mL complete blood count with differential. The attending now requests an additional 1 mL chemistry panel. Approximately what proportion of this infant's circulating blood volume will have been removed in 24 hours, and what is the most appropriate pharmacist response?
A nurse reports a capillary heel-stick potassium of 7.3 mEq/L in a well-appearing, vigorous 5-day-old term newborn who is feeding normally. The ECG shows a normal QRS duration with no peaked T waves, and urine output is 3 mL/kg/hour. What should the pediatric clinical pharmacist recommend first?
A 6-year-old receiving extended-interval tobramycin for a cystic fibrosis exacerbation is scheduled for a peak concentration after the third dose. The 30-minute infusion ends at 10:00. At which time should the peak concentration be drawn, and why?